share_log

多瑞医药:中信证券股份有限公司关于西藏多瑞医药股份有限公司2023年度持续督导定期现场检查报告

Tibet Duo Rui Pharmaceutical: CITIC Securities Co., Ltd. report on the 2023 continuous supervision and regular on-site inspection report of Tibet Dorui Pharmaceutical Co., Ltd.

Sensex a share ·  May 7
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more